Literature DB >> 1550775

Cell cycle analysis in lymphoid neoplasia of childhood: differences among immunologic subtypes and similarities in the proliferation of normal and leukaemic precursor B cells.

A Hirt1, E M Werren, A R Luethy, J Gerdes, H P Wagner.   

Abstract

Cell proliferation in untreated lymphoid malignancies of children was investigated by an in vitro assessment of the 3H-thymidine labelling index (LI), the growth fraction (GF) with the monoclonal antibody Ki-67, and the duration of the DNA-synthesis phase (ts) with a double labelling technique. Mean cell cycle time (tg) was similar in lymphoid malignancies of precursor B cell and T cell origin (115 h and 102 h, respectively), while B cell neoplasias had a mean tg of only 25 h. A positive correlation between the LI and the GF (r = 0.892) and a negative correlation between the LI and tg (r = -0.908) could be detected in childhood lymphoid malignancies. The proliferation of neoplastic precursor B cells was compared with the proliferation of presumably normal terminal transferase (TdT) positive bone marrow cells that, according to the immunophenotype, correspond mainly to normal precursor B cells. Although mean ts was identical in both cell populations (18-19 h), the neoplastic cell population showed a significantly longer mean tg than the normal counterpart (115 h and 65 h, respectively). However, if malignant and normal precursor B cell populations with a similar LI were compared, the difference in tg disappeared. Therefore, a down-regulation of leukaemic cell proliferation by an increasing cell mass is postulated for most cases of untreated precursor B cell ALL.

Entities:  

Mesh:

Year:  1992        PMID: 1550775     DOI: 10.1111/j.1365-2141.1992.tb08899.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  A study on the predictability of acute lymphoblastic leukaemia response to treatment using a hybrid oncosimulator.

Authors:  Eleftherios Ouzounoglou; Eleni Kolokotroni; Martin Stanulla; Georgios S Stamatakos
Journal:  Interface Focus       Date:  2017-12-15       Impact factor: 3.906

2.  Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.

Authors:  A H Beesley; M-L Palmer; J Ford; R E Weller; A J Cummings; J R Freitas; M J Firth; K U Perera; N H de Klerk; U R Kees
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

3.  Differentiation resistance through altered retinoblastoma protein function in acute lymphoblastic leukemia: in silico modeling of the deregulations in the G1/S restriction point pathway.

Authors:  Eleftherios Ouzounoglou; Dimitra Dionysiou; Georgios S Stamatakos
Journal:  BMC Syst Biol       Date:  2016-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.